1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Drug Discovery and Development Industry in China Market Research & Statistics

Drug Discovery and Development Industry in China Market Research & Statistics

24/7 Customer Support

Talk to Sam

+1 718 473 0872

All regions

50 reports

Download Unlimited Documents from Trusted Public Sources

Drug Discovery And Development Industry in China

  • October 2015
    15 pages
  • Drug Discovery ...  

  • China  

View report >

Renal Disease and Diabetes Statistics in China - Forecast

  • June 2016
    3 pages
  • Renal Disease  

    Diabetes  

    Biosimilar  

  • China  

    Asia  

View report >

Drug Discovery And Development Industry in China and Mexico - Forecast

  • June 2016
    4 pages
  • Drug Discovery ...  

  • China  

    Mexico  

View report >

Genome Sequencing Industry in China

  • April 2016
    15 pages
  • Genome Sequenci...  

    MALDI TOF  

  • China  

View report >

Clinical Trial Industry

  • January 2016
    4 pages
  • Clinical Trial  

  • United States  

View report >

Pharmaceutical Market in China

  • January 2016
    2 pages
  • Pharmaceutical  

    Dementia  

    Clinical Trial  

  • China  

View report >

Clinical Trial Forecast in China

  • October 2015
    2 pages
  • Clinical Trial  

  • China  

View report >

Diabetes Statistics in China - Forecast

  • October 2015
    3 pages
  • Diabetes  

    Pharmaceutical  

    Clinical Trial  

  • China  

    Asia  

View report >

Clinical Trial Industry in China

  • June 2015
    16 pages
  • Clinical Trial  

  • China  

    Asia  

    South Korea  

View report >

Drug Discovery And Development Supply in China and Asia

  • January 2015
    3 pages
  • Drug Discovery ...  

  • China  

    Asia  

    World  

View report >


40 reports

Purchase Reports From Reputable Market Research Publishers
(From $ 2 800 - $ 4 995)

Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2022 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2022 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market

  • $ 4 995
  • Industry report
  • May 2016
  • by GBI Research

Non-Small Cell Lung Cancer Therapeutics in Asia-Pacific Markets to 2022 - Launch of Premium Targeted Therapies and Increasing Prevalence to Drive the Market Summary Non-Small Cell Lung Cancer (NSCLC) is ...

Outsourcing In Drug Discovery, 7th Edition

April 2016 $ 4 200

Global Cloud Computing In Pharmaceutical Research And D ...

April 2016 $ 2 800

Fibrinogen Deficiency (factor I Deficiency) - Pipeline ...

March 2016 $ 2 000

Dental Bone Graft Substitutes - Medical Devices Pipelin ...

March 2016 $ 2 500

Ige Allergy Blood Tests - Medical Devices Pipeline Asse ...

March 2016 $ 2 500

Shangpharma – Qidong Pre-clinical Research Facility ...

January 2016 $ 75

Lifebond Ltd. - Product Pipeline Analysis, 2015 Update

December 2015 $ 750

Advanced Bionics, Llc - Product Pipeline Analysis, 2015 ...

December 2015 $ 750

Sareum Holdings Plc - Product Pipeline Review - 2015

December 2015 $ 1 500

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.